Haleon confirms outlook despite 'challenging' backdrop

30th Apr 2025 09:51

(Sharecast News) - Consumer healthcare giant Haleon reiterated its full-year guidance on Wednesday, despite an increasingly "challenging and uncertain" macroeconomic backdrop.

Read more

Haleon to take full ownership of Chinese joint venture

15th Apr 2025 10:04

(Sharecast News) - Haleon announced on Tuesday that it has agreed to acquire the remaining 12% stake in its Chinese over-the-counter joint venture, Tianjin TSKF Pharmaceutical, for CNY 1.623bn (around £200m), bringing its total ownership to 100%.

Read more

Haleon launches £330m share buyback programme

28th Mar 2025 08:29

(Sharecast News) - Haleon launched a share buyback programme of up to £330m on Friday, representing the remaining portion of the £500m allocated for repurchases in 2025.

Read more

Pfizer exits Haleon with £2.4bn stake sale

19th Mar 2025 07:18

(Sharecast News) - Pfizer has fully exited its investment in UK-listed pharma group Haleon, selling off its remaining 7.3% stake for £2.5bn.

Read more

London close: Stocks mixed on corporate earnings, Trump tariff threats

27th Feb 2025 15:43

(Sharecast News) - London stocks closed in a mixed state on Thursday, with the top-flight index recovering from a weaker open as investors absorbed fresh US jobless claims data and a wave of corporate earnings reports.

Read more

Annual sales, profits jump at Haleon

27th Feb 2025 07:30

(Sharecast News) - Consumer healthcare giant Haleon reiterated its full-year outlook on Thursday, after posting improved full-year sales and profits.

Read more

Pfizer pares back Haleon stake in £2.5bn sale

15th Jan 2025 08:10

(Sharecast News) - Pfizer has further reduced its holding in Haleon, it was confirmed on Wednesday, after the drugs giant offloaded 700m shares in a £2.5bn sale.

Read more

London close: Stocks fall after better-than-expected US payrolls

10th Jan 2025 16:11

(Sharecast News) - London stocks ended the week lower, with investors reacting to a better-than-expected US nonfarm payrolls report during the afternoon.

Read more

Morgan Stanley upgrades Reckitt, downgrades Haleon

10th Jan 2025 09:25

(Sharecast News) - Morgan Stanley upgraded Reckitt Benckiser and downgraded Haleon on Friday as it took a look at consumer staples stocks.

Read more

Haleon completes purchase of 33pc share in Chinese JV

31st Dec 2024 12:30

(Sharecast News) - Haleon announced on Tuesday that it has finalised the acquisition of an additional 33% equity stake in its Chinese joint venture, Tianjin TSKF Pharmaceutical Co (TSKF), from Tianjin Pharmaceutical Group and Tianjin Pharmaceutical Da Ren Tang Group Corporation.

Read more

Director dealings: Haleon's Alan Stewart snaps up shares

8th Nov 2024 15:33

(Sharecast News) - Haleon revealed on Friday that non-executive director Alan Stewart had acquired 33,923 ordinary shares in the London-listed consumer healthcare business.

Read more

London close: Stocks down on corporate earnings, Budget fallout

31st Oct 2024 15:59

(Sharecast News) - London stocks ended Thursday in negative territory, weighed down by corporate earnings releases and the market's response to the new Labour government's budget unveiled on Wednesday.

Read more

Haleon 'on track' for full year, notwithstanding currency headwinds

31st Oct 2024 07:04

(Sharecast News) - Haleon reported organic revenue growth of 6.1% for the third quarter on Thursday, driven by balanced increases in both price and volume/mix at 3.3% and 2.8% respectively, though reported revenue declined by 0.6% due to currency impacts.

Read more

Futura Medical due $5m milestone payment from Haleon

7th Oct 2024 14:17

(Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.

Read more

Haleon buys back £230m in shares after Pfizer offloads £2.43bn stake

1st Oct 2024 07:48

(Sharecast News) - Pharma giant Pfizer has offloaded a £2.43bn stake in Haleon, which in turn said it would buy back £230m of the shares.

Read more